Interest Expense of BIO-TECHNE Corp from 30 Jun 2013 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
BIO-TECHNE Corp quarterly and annual Interest Expense in USD history and change rate from 30 Jun 2013 to 31 Mar 2024.
  • BIO-TECHNE Corp Interest Expense for the quarter ending 31 Mar 2024 was $4,005,000, a 193% increase year-over-year.
  • BIO-TECHNE Corp Interest Expense for the twelve months ending 31 Mar 2024 was $16,929,000, a 69% increase year-over-year.
  • BIO-TECHNE Corp annual Interest Expense for 2023 was $11,215,000, a 0.83% decline from 2022.
  • BIO-TECHNE Corp annual Interest Expense for 2022 was $11,309,000, a 19% decline from 2021.
  • BIO-TECHNE Corp annual Interest Expense for 2021 was $13,952,000, a 27% decline from 2020.
Source SEC data
View on sec.gov
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

BIO-TECHNE Corp Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $16,929,000 $4,005,000 +$2,638,000 +193% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2024 2024 Q3
Q4 2023 $14,291,000 $4,329,000 +$1,973,000 +84% 01 Oct 2023 31 Dec 2023 10-Q 07 Feb 2024 2024 Q2
Q3 2023 $12,318,000 $4,893,000 +$1,103,000 +29% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2023 2024 Q1
Q2 2023 $11,215,000 $3,702,000 +$1,197,000 +48% 01 Apr 2023 30 Jun 2023 10-K 23 Aug 2023 2023 FY
Q1 2023 $10,018,000 $1,367,000 -$1,126,000 -45% 01 Jan 2023 31 Mar 2023 10-Q 06 May 2024 2024 Q3
Q4 2022 $11,144,000 $2,356,000 -$546,000 -19% 01 Oct 2022 31 Dec 2022 10-Q 07 Feb 2024 2024 Q2
Q3 2022 $11,690,000 $3,790,000 +$381,000 +11% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023 2024 Q1
Q2 2022 $11,309,000 $2,505,000 -$786,000 -24% 01 Apr 2022 30 Jun 2022 10-K 23 Aug 2023 2023 FY
Q1 2022 $12,095,000 $2,493,000 -$167,000 -6.3% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023 2023 Q3
Q4 2021 $12,262,000 $2,902,000 -$683,000 -19% 01 Oct 2021 31 Dec 2021 10-Q 07 Feb 2023 2023 Q2
Q3 2021 $12,945,000 $3,409,000 -$1,007,000 -23% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022 2023 Q1
Q2 2021 $13,952,000 $3,291,000 -$1,326,000 -29% 01 Apr 2021 30 Jun 2021 10-K 23 Aug 2023 2023 FY
Q1 2021 $15,278,000 $2,660,000 -$1,826,000 -41% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q3
Q4 2020 $17,104,000 $3,585,000 -$1,287,000 -26% 01 Oct 2020 31 Dec 2020 10-Q 07 Feb 2022 2022 Q2
Q3 2020 $18,391,000 $4,416,000 -$806,000 -15% 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021 2022 Q1
Q2 2020 $19,197,000 $4,617,000 -$977,000 -17% 01 Apr 2020 30 Jun 2020 10-K 24 Aug 2022 2022 FY
Q1 2020 $20,174,000 $4,486,000 -$627,000 -12% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021 2021 Q3
Q4 2019 $20,801,000 $4,872,000 -$887,000 -15% 01 Oct 2019 31 Dec 2019 10-Q 08 Feb 2021 2021 Q2
Q3 2019 $21,688,000 $5,222,000 -$17,000 -0.32% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020 2021 Q1
Q2 2019 $21,705,000 $5,594,000 +$2,540,000 +83% 01 Apr 2019 30 Jun 2019 10-K 25 Aug 2021 2021 FY
Q1 2019 $19,165,000 $5,113,000 +$2,553,000 +100% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q3
Q4 2018 $16,612,000 $5,759,000 +$3,428,000 +147% 01 Oct 2018 31 Dec 2018 10-Q 06 Feb 2020 2020 Q2
Q3 2018 $13,184,000 $5,239,000 +$2,996,000 +134% 01 Jul 2018 30 Sep 2018 10-Q 06 Nov 2019 2020 Q1
Q2 2018 $10,188,000 $3,054,000 +$1,122,000 +58% 01 Apr 2018 30 Jun 2018 10-K 26 Aug 2020 2020 FY
Q1 2018 $9,066,000 $2,560,000 +$452,000 +21% 01 Jan 2018 31 Mar 2018 10-Q 07 May 2019 2019 Q3
Q4 2017 $8,614,000 $2,331,000 +$410,000 +21% 01 Oct 2017 31 Dec 2017 10-Q 07 Feb 2019 2019 Q2
Q3 2017 $8,204,000 $2,243,000 +$843,000 +60% 01 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018 2019 Q1
Q2 2017 $7,361,000 $1,932,000 +$1,483,000 +330% 01 Apr 2017 30 Jun 2017 10-K/A 06 Nov 2019 2019 FY
Q1 2017 $5,878,000 $2,108,000 +$1,660,000 +371% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018 2018 Q3
Q4 2016 $4,218,000 $1,921,000 +$1,521,000 +380% 01 Oct 2016 31 Dec 2016 10-Q 08 Feb 2018 2018 Q2
Q3 2016 $2,697,000 $1,400,000 +$949,000 +210% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017 2018 Q1
Q2 2016 $1,748,000 $449,000 +$67,000 +18% 01 Apr 2016 30 Jun 2016 10-K 27 Aug 2018 2018 FY
Q1 2016 $1,681,000 $448,000 +$34,000 +8.2% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q3
Q4 2015 $1,647,000 $400,000 -$37,000 -8.5% 01 Oct 2015 31 Dec 2015 10-Q 09 Feb 2017 2017 Q2
Q3 2015 $1,684,000 $451,000 +$140,000 +45% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016 2017 Q1
Q2 2015 $1,544,000 $382,000 01 Apr 2015 30 Jun 2015 10-K 07 Sep 2017 2017 FY
Q1 2015 $414,000 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016 2016 Q3
Q4 2014 $437,000 +$437,000 01 Oct 2014 31 Dec 2014 10-Q 09 Feb 2016 2016 Q2
Q3 2014 $311,000 +$311,000 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015 2016 Q1
Q4 2013 $0 01 Oct 2013 31 Dec 2013 10-Q 09 Feb 2015 2015 Q2
Q3 2013 $0 01 Jul 2013 30 Sep 2013 10-Q 10 Nov 2014 2015 Q1

BIO-TECHNE Corp Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $11,215,000 -$94,000 -0.83% 01 Jul 2022 30 Jun 2023 10-K 23 Aug 2023 2023 FY
2022 $11,309,000 -$2,643,000 -19% 01 Jul 2021 30 Jun 2022 10-K 23 Aug 2023 2023 FY
2021 $13,952,000 -$5,245,000 -27% 01 Jul 2020 30 Jun 2021 10-K 23 Aug 2023 2023 FY
2020 $19,197,000 -$2,508,000 -12% 01 Jul 2019 30 Jun 2020 10-K 24 Aug 2022 2022 FY
2019 $21,705,000 +$11,517,000 +113% 01 Jul 2018 30 Jun 2019 10-K 25 Aug 2021 2021 FY
2018 $10,188,000 +$2,827,000 +38% 01 Jul 2017 30 Jun 2018 10-K 26 Aug 2020 2020 FY
2017 $7,361,000 +$5,613,000 +321% 01 Jul 2016 30 Jun 2017 10-K/A 06 Nov 2019 2019 FY
2016 $1,748,000 +$204,000 +13% 01 Jul 2015 30 Jun 2016 10-K 27 Aug 2018 2018 FY
2015 $1,544,000 +$1,544,000 01 Jul 2014 30 Jun 2015 10-K 07 Sep 2017 2017 FY
2014 $0 $0 01 Jul 2013 30 Jun 2014 10-K 29 Aug 2016 2016 FY
2013 $0 01 Jul 2012 30 Jun 2013 10-K 31 Aug 2015 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.